Overview
- The University of Richmond announced Sunday that forward Jack McCaffery has been diagnosed with Hodgkin's lymphoma and will take an indefinite leave from the team.
- After an evaluation by Richmond medical staff this week, McCaffery traveled home to Philadelphia and was admitted to the Hospital of the University of Pennsylvania to begin treatment under Penn Medicine.
- Penn Medicine said its lymphoma team is confident in the treatment plan and noted that Hodgkin's lymphoma most often affects young adults but is a highly curable form of cancer.
- McCaffery transferred to Richmond this offseason after a freshman year at Butler that ended early due to illness and complications from wisdom teeth removal, and he entered college as a four-star recruit in the 2025 class.
- Richmond coach Chris Mooney and McCaffery's family have pledged program support while doctors set an individualized treatment timeline and no date has been given for a return to basketball.